| No. | Document Title | ID | Updated | Views |
|---|---|---|---|---|
| 41 | FDA Approval Date | 101806 | 2022-12-02 | 212 |
| 42 | IND/IDE Submit Date | 101805 | 2022-12-02 | 178 |
| 43 | Grantor | 101804 | 2022-12-02 | 169 |
| 44 | NCI/NIH Institution | 101803 | 2022-12-02 | 176 |
| 45 | Investigational Drug/Device | 101800 | 2022-12-02 | 177 |
| 46 | Fund Account No. | 101797 | 2022-11-29 | 237 |
| 47 | Sponsor Protocol No. | 101796 | 2022-11-29 | 176 |
| 48 | Sponsor Type | 101795 | 2022-11-29 | 228 |
| 49 | Staff: Stop Reason | 101793 | 2022-11-29 | 187 |
| 50 | Staff: Stop Date | 101792 | 2022-11-29 | 200 |
| 51 | Staff: Start Date | 101791 | 2022-11-29 | 194 |
| 52 | Protocol Staff Role | 70715 | 2022-11-29 | 281 |
| 53 | Managment Group | 101788 | 2022-11-29 | 227 |
| 54 | Toxicity Scheme | 24235 | 2022-11-25 | 272 |
| 55 | Pharmacy No. | 122680 | 2022-11-25 | 186 |
| 56 | Subject Visits Update OnCore Tutorial [Campus login required] | 42260 | 2024-04-01 | 46 |
Not finding what you are looking for? Suggest a new document be created.